docetaxel anhydrous has been researched along with Acrospiroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bree, E; Panagiotidis, J; Romanos, J; Tsetis, D; Tsiftsis, DD; Varthalitis, Y; Volalakis, E | 1 |
| Hanby, AM; Miles, DW; Plunkett, TA; Rubens, RD | 1 |
2 other study(ies) available for docetaxel anhydrous and Acrospiroma
| Article | Year |
|---|---|
Treatment of advanced malignant eccrine poroma with locoregional chemotherapy.
Topics: Acrospiroma; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Fluorouracil; Humans; Leg; Male; Skin Neoplasms; Sweat Gland Neoplasms; Taxoids | 2005 |
Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.
Topics: Acrospiroma; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Middle Aged; Paclitaxel; Sweat Gland Neoplasms; Taxoids; Thorax; Tomography, X-Ray Computed | 2001 |